Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

JNJ-10258859: a novel PDE5 inhibitor with potential in erectile dysfunction

July 14, 2003

Series of potassium channel modulators and their use reported by Wyeth

July 14, 2003

Use of dopamine D3 agonists in sexual dysfunction

July 11, 2003

Human arginase II: a possible target for the treatment of sexual arousal disorders

July 10, 2003

Muscarinic M2/M3 receptor antagonists for urinary incontinence and other uses

July 4, 2003

FDA accepts the NDA for trospium

July 4, 2003

Lilly Icos submits complete response to FDA for Cialis

July 4, 2003

Yamanouchi prepares and tests new vasopressin V2 ligands

June 25, 2003

Extended-release alfuzosin approved for BPH

June 18, 2003

Long-term efficacy and safety results reported for lanthanum carbonate in chronic renal failure

June 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...